世界の医療用ナノ技術(ナノ医療)市場2020-2027:疾患別(心血管疾患、腫瘍性疾患、神経疾患・その他)、用途別、地域別

◆英語タイトル:Global Healthcare Nanotechnology (Nanomedicine) Market Size study, by Diseases (Cardiovascular Diseases, Oncological Diseases, Neurological Diseases and Others), Application (Drug Delivery, Biomaterials, Active Implants and Others) and Regional Forecasts 2020-2027
◆商品コード:BZW21AP099
◆発行会社(リサーチ会社):Bizwit Research&Consulting
◆発行日:2021年2月15日
◆ページ数:約200
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:アメリカ、カナダ、イギリス、ドイツ、フランス、スペイン、イタリア、中国、インド、日本、オーストラリア、韓国、ブラジル、メキシコ、GCC諸国
◆販売価格オプション(消費税別)
Single User(1名様閲覧用、印刷不可)USD4,950 ⇒換算¥544,500見積依頼/購入/質問フォーム
Enterprisewide(同一法人内共有可)USD6,250 ⇒換算¥687,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はBizwit Research&Consulting社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Bizwit Research&Consulting社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本書では、世界の医療用ナノ技術(ナノ医療)市場を調査対象とし、エグゼクティブサマリー、市場定義・範囲、市場動向、産業分析、疾患別(心血管疾患、腫瘍性疾患、神経疾患、その他)分析、用途別(薬物送達、生体材料、アクティブインプラント、その他)分析、地域別分析、競争状況、調査プロセスなどを整理しました。
・エグゼクティブサマリー
・市場定義・範囲
・市場動向
・産業分析
・世界の医療用ナノ技術(ナノ医療)市場規模:疾患別(心血管疾患、腫瘍性疾患、神経疾患、その他)
・世界の医療用ナノ技術(ナノ医療)市場規模:用途別(薬物送達、生体材料、アクティブインプラント、その他)
・世界の医療用ナノ技術(ナノ医療)市場規模:地域別
・競争状況
・調査プロセス
【レポートの概要】

Global Healthcare Nanotechnology (Nanomedicine) Market is valued approximately USD 196.47 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 11.9 % over the forecast period 2020-2027. Healthcare Nanotechnology (Nanomedicine) is the product which is nano-formulations of the existing drugs or new drugs or nanomaterials. Nanomedicine helps in improving human health by providing solutions for various life-threatening diseases, like cancer, Parkinson’s disease, Alzheimer’s disease, diabetes, orthopedic diseases, and infections blood, lungs, and cardiovascular system. For instance: according to the Alzheimer’s Disease International, there were around 50 million people globally with dementia in 2020, which is expected to double every 20 years.

According to the Globocan 2020, the global cancer burden increased to 19.3 million cases and 10 million cancer deaths in 2020. This will increase the demand for effective nanomedicines in the management of the diseases. Further, increasing investments in urgent care, increasing geriatric population and strategic development between hospitals and the manufacturers has led the adoption of Healthcare Nanotechnology (Nanomedicine) across the forecast period. The market has seen positive growth due to investments in new products by research & development. For Instance: in 2020, Medtronic PLC launched navigated titanium spinal implant, its new Adaptix Interbody System which is with the Titan nanoLOCK Surface Technology. In 2019, Nanobiotix, a clinical stage nanomedicine company had obtained the CE approval for its Hensify (NBTXR3), nanoparticles designed for injection directly into a tumor. However, stringent regulatory issues and high cost of nano-medicines compared to the traditional medicines along with low awareness among consumers in low income countries impedes the growth of the market over the forecast period of 2020-2027. Also, with the increasing prevalence of diseases, technological advancements for early disease diagnosis & preventive intervention the adoption & demand for Healthcare Nanotechnology (Nanomedicine) is likely to increase.

The regional analysis of global Healthcare Nanotechnology (Nanomedicine) market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the growing geriatric population and promptness & affordability of nano-medicines coupled with the well-established healthcare infrastructure along with the huge investments in research & development activities. For instance: according to the www.acc.org, in 2018, coronary heart disease was the leading cause of deaths attributable to cardiovascular disease in the United States with 43.8% of total CVD deaths. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2020-2027. Factors such as rise in research grants, increasing venture capital investors from developing economies of this region and increasing international research collaborations along with the improving healthcare infrastructure would create lucrative growth prospects for the Healthcare Nanotechnology (Nanomedicine) market across Asia-Pacific region.

Major market player included in this report are:
Abbott Laboratories
CombiMatrix Corporation
GE Healthcare
Sigma-Tau Pharmaceuticals, Inc.
Johnson & Johnson
Mallinckrodt plc
Merck & Company, Inc.
Nanosphere, Inc.
Pfizer, Inc.
Celgene Corporation

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players.

The detailed segments and sub-segment of the market are explained below:

By Diseases:
Cardiovascular Diseases
Oncological Diseases
Neurological Diseases
Others

By Application:
Drug Delivery
Biomaterials
Active Implants
Others

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2017, 2018
Base year – 2019
Forecast period – 2020 to 2027

Target Audience of the Global Healthcare Nanotechnology (Nanomedicine) Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

【レポートの目次】

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2018-2027 (USD Billion)
1.2.1. Healthcare Nanotechnology (Nanomedicine) Market, by Region, 2018-2027 (USD Billion)
1.2.2. Healthcare Nanotechnology (Nanomedicine) Market, by Diseases, 2018-2027 (USD Billion)
1.2.3. Healthcare Nanotechnology (Nanomedicine) Market, by Application, 2018-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Healthcare Nanotechnology (Nanomedicine) Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Healthcare Nanotechnology (Nanomedicine) Market Dynamics
3.1. Healthcare Nanotechnology (Nanomedicine) Market Impact Analysis (2018-2027)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Global Healthcare Nanotechnology (Nanomedicine) Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2017-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Healthcare Nanotechnology (Nanomedicine) Market, by Diseases
5.1. Market Snapshot
5.2. Global Healthcare Nanotechnology (Nanomedicine) Market by Diseases, Performance – Potential Analysis
5.3. Global Healthcare Nanotechnology (Nanomedicine) Market Estimates & Forecasts by Diseases 2017-2027 (USD Billion)
5.4. Healthcare Nanotechnology (Nanomedicine) Market, Sub Segment Analysis
5.4.1. Cardiovascular Diseases
5.4.2. Oncological Diseases
5.4.3. Neurological Diseases
5.4.4. Others
Chapter 6. Global Healthcare Nanotechnology (Nanomedicine) Market, by Application
6.1. Market Snapshot
6.2. Global Healthcare Nanotechnology (Nanomedicine) Market by Application, Performance – Potential Analysis
6.3. Global Healthcare Nanotechnology (Nanomedicine) Market Estimates & Forecasts by Application 2017-2027 (USD Billion)
6.4. Healthcare Nanotechnology (Nanomedicine) Market, Sub Segment Analysis
6.4.1. Drug Delivery
6.4.2. Biomaterials
6.4.3. Active Implants
6.4.4. Others
Chapter 7. Global Healthcare Nanotechnology (Nanomedicine) Market, Regional Analysis
7.1. Healthcare Nanotechnology (Nanomedicine) Market, Regional Market Snapshot
7.2. North America Healthcare Nanotechnology (Nanomedicine) Market
7.2.1. U.S. Healthcare Nanotechnology (Nanomedicine) Market
7.2.1.1. Diseases breakdown estimates & forecasts, 2017-2027
7.2.1.2. Application breakdown estimates & forecasts, 2017-2027
7.2.2. Canada Healthcare Nanotechnology (Nanomedicine) Market
7.3. Europe Healthcare Nanotechnology (Nanomedicine) Market Snapshot
7.3.1. U.K. Healthcare Nanotechnology (Nanomedicine) Market
7.3.2. Germany Healthcare Nanotechnology (Nanomedicine) Market
7.3.3. France Healthcare Nanotechnology (Nanomedicine) Market
7.3.4. Spain Healthcare Nanotechnology (Nanomedicine) Market
7.3.5. Italy Healthcare Nanotechnology (Nanomedicine) Market
7.3.6. Rest of Europe Healthcare Nanotechnology (Nanomedicine) Market
7.4. Asia-Pacific Healthcare Nanotechnology (Nanomedicine) Market Snapshot
7.4.1. China Healthcare Nanotechnology (Nanomedicine) Market
7.4.2. India Healthcare Nanotechnology (Nanomedicine) Market
7.4.3. Japan Healthcare Nanotechnology (Nanomedicine) Market
7.4.4. Australia Healthcare Nanotechnology (Nanomedicine) Market
7.4.5. South Korea Healthcare Nanotechnology (Nanomedicine) Market
7.4.6. Rest of Asia Pacific Healthcare Nanotechnology (Nanomedicine) Market
7.5. Latin America Healthcare Nanotechnology (Nanomedicine) Market Snapshot
7.5.1. Brazil Healthcare Nanotechnology (Nanomedicine) Market
7.5.2. Mexico Healthcare Nanotechnology (Nanomedicine) Market
7.6. Rest of The World Healthcare Nanotechnology (Nanomedicine) Market

Chapter 8. Competitive Intelligence
8.1. Top Market Strategies
8.2. Company Profiles
8.2.1. Abbott Laboratories
8.2.1.1. Key Information
8.2.1.2. Overview
8.2.1.3. Financial (Subject to Data Availability)
8.2.1.4. Product Summary
8.2.1.5. Recent Developments
8.2.2. CombiMatrix Corporation
8.2.3. GE Healthcare
8.2.4. Sigma-Tau Pharmaceuticals, Inc.
8.2.5. Johnson & Johnson
8.2.6. Mallinckrodt plc
8.2.7. Merck & Company, Inc.
8.2.8. Nanosphere, Inc.
8.2.9. Pfizer, Inc.
8.2.10. Celgene Corporation
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption

List of Tables
TABLE 1. Global Healthcare Nanotechnology (Nanomedicine) market, report scope
TABLE 2. Global Healthcare Nanotechnology (Nanomedicine) market estimates & forecasts by Region 2017-2027 (USD Billion)
TABLE 3. Global Healthcare Nanotechnology (Nanomedicine) market estimates & forecasts by Diseases 2017-2027 (USD Billion)
TABLE 4. Global Healthcare Nanotechnology (Nanomedicine) market estimates & forecasts by Application 2017-2027 (USD Billion)
TABLE 5. Global Healthcare Nanotechnology (Nanomedicine) market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 6. Global Healthcare Nanotechnology (Nanomedicine) market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 7. Global Healthcare Nanotechnology (Nanomedicine) market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 8. Global Healthcare Nanotechnology (Nanomedicine) market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 9. Global Healthcare Nanotechnology (Nanomedicine) market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 10. Global Healthcare Nanotechnology (Nanomedicine) market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 11. Global Healthcare Nanotechnology (Nanomedicine) market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 12. Global Healthcare Nanotechnology (Nanomedicine) market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 13. Global Healthcare Nanotechnology (Nanomedicine) market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 14. Global Healthcare Nanotechnology (Nanomedicine) market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 15. U.S. Healthcare Nanotechnology (Nanomedicine) market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 16. U.S. Healthcare Nanotechnology (Nanomedicine) market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 17. U.S. Healthcare Nanotechnology (Nanomedicine) market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 18. Canada Healthcare Nanotechnology (Nanomedicine) market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 19. Canada Healthcare Nanotechnology (Nanomedicine) market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 20. Canada Healthcare Nanotechnology (Nanomedicine) market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 21. UK Healthcare Nanotechnology (Nanomedicine) market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 22. UK Healthcare Nanotechnology (Nanomedicine) market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 23. UK Healthcare Nanotechnology (Nanomedicine) market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 24. Germany Healthcare Nanotechnology (Nanomedicine) market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 25. Germany Healthcare Nanotechnology (Nanomedicine) market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 26. Germany Healthcare Nanotechnology (Nanomedicine) market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 27. RoE Healthcare Nanotechnology (Nanomedicine) market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 28. RoE Healthcare Nanotechnology (Nanomedicine) market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 29. RoE Healthcare Nanotechnology (Nanomedicine) market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 30. China Healthcare Nanotechnology (Nanomedicine) market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 31. China Healthcare Nanotechnology (Nanomedicine) market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 32. China Healthcare Nanotechnology (Nanomedicine) market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 33. India Healthcare Nanotechnology (Nanomedicine) market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 34. India Healthcare Nanotechnology (Nanomedicine) market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 35. India Healthcare Nanotechnology (Nanomedicine) market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 36. Japan Healthcare Nanotechnology (Nanomedicine) market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 37. Japan Healthcare Nanotechnology (Nanomedicine) market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 38. Japan Healthcare Nanotechnology (Nanomedicine) market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 39. RoAPAC Healthcare Nanotechnology (Nanomedicine) market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 40. RoAPAC Healthcare Nanotechnology (Nanomedicine) market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 41. RoAPAC Healthcare Nanotechnology (Nanomedicine) market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 42. Brazil Healthcare Nanotechnology (Nanomedicine) market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 43. Brazil Healthcare Nanotechnology (Nanomedicine) market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 44. Brazil Healthcare Nanotechnology (Nanomedicine) market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 45. Mexico Healthcare Nanotechnology (Nanomedicine) market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 46. Mexico Healthcare Nanotechnology (Nanomedicine) market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 47. Mexico Healthcare Nanotechnology (Nanomedicine) market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 48. RoLA Healthcare Nanotechnology (Nanomedicine) market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 49. RoLA Healthcare Nanotechnology (Nanomedicine) market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 50. RoLA Healthcare Nanotechnology (Nanomedicine) market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 51. Row Healthcare Nanotechnology (Nanomedicine) market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 52. Row Healthcare Nanotechnology (Nanomedicine) market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 53. Row Healthcare Nanotechnology (Nanomedicine) market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 54. List of secondary sources, used in the study of global Healthcare Nanotechnology (Nanomedicine) market
TABLE 55. List of primary sources, used in the study of global Healthcare Nanotechnology (Nanomedicine) market
TABLE 56. Years considered for the study
TABLE 57. Exchange rates considered

List of figures
FIG 1. Global Healthcare Nanotechnology (Nanomedicine) market, research methodology
FIG 2. Global Healthcare Nanotechnology (Nanomedicine) market, market estimation techniques
FIG 3. Global market size estimates & forecast methods
FIG 4. Global Healthcare Nanotechnology (Nanomedicine) market, key trends 2019
FIG 5. Global Healthcare Nanotechnology (Nanomedicine) market, growth prospects 2020-2027
FIG 6. Global Healthcare Nanotechnology (Nanomedicine) market, porters 5 force model
FIG 7. Global Healthcare Nanotechnology (Nanomedicine) market, pest analysis
FIG 8. Global Healthcare Nanotechnology (Nanomedicine) market, value chain analysis
FIG 9. Global Healthcare Nanotechnology (Nanomedicine) market by segment, 2017 & 2027 (USD Billion)
FIG 10. Global Healthcare Nanotechnology (Nanomedicine) market by segment, 2017 & 2027 (USD Billion)
FIG 11. Global Healthcare Nanotechnology (Nanomedicine) market by segment, 2017 & 2027 (USD Billion)
FIG 12. Global Healthcare Nanotechnology (Nanomedicine) market by segment, 2017 & 2027 (USD Billion)
FIG 13. Global Healthcare Nanotechnology (Nanomedicine) market by segment, 2017 & 2027 (USD Billion)
FIG 14. Global Healthcare Nanotechnology (Nanomedicine) market, regional snapshot 2017 & 2027
FIG 15. North America Healthcare Nanotechnology (Nanomedicine) market 2017 & 2027 (USD Billion)
FIG 16. Europe Healthcare Nanotechnology (Nanomedicine) market 2017 & 2027 (USD Billion)
FIG 17. Asia pacific Healthcare Nanotechnology (Nanomedicine) market 2017 & 2027 (USD Billion)
FIG 18. Latin America Healthcare Nanotechnology (Nanomedicine) market 2017 & 2027 (USD Billion)
FIG 19. Global Healthcare Nanotechnology (Nanomedicine) market, company market share analysis (2019)

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[世界の医療用ナノ技術(ナノ医療)市場2020-2027:疾患別(心血管疾患、腫瘍性疾患、神経疾患・その他)、用途別、地域別]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆